Arca Biopharma | ABIO - Net Income


Arca Biopharma reported $-31.82M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Amgen USD 3.86B 1.49B Sep/2026
Arca Biopharma USD -31.82M 2.24M Mar/2026
Biogen USD 97.5M 222M Jun/2026
Brainstorm Cell Therapeutics USD -2.13M 21K Mar/2026
Bristol-Myers Squibb USD 2.16B 1.16B Sep/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 8.78B 884.9M Sep/2026
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -7.01M 663K Jun/2026
CSL USD 401M 96.5M Dec/2025
Cytokinetics USD -190.07M 8.69M Sep/2026
Daiichi Sankyo JPY 82.9B 14.26B Sep/2026
Gilead Sciences USD -10.5B 12.52B Jun/2026
GlaxoSmithKline GBP 1.54B 1.11B Sep/2026
Grifols EUR 114.37M 34.03M Dec/2025
Laboratory Of America USD 262.8M 35.9M Sep/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Otsuka Holdings JPY 106.49B 10.77B Sep/2026
Pfizer USD 3.24B 3.49B Sep/2026
United Therapeutics USD 258.6M 74.4M Sep/2026